Client develops therapeutics to treat multi-drug resistant bacterial infections.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2013 | THE MCMANUS GROUP |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | |
| 2013 | THE MCMANUS GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2013 | THE MCMANUS GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2013 | THE MCMANUS GROUP |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| THE MCMANUS GROUP | 25 | — |
| Issue | Activities |
|---|---|
| Health Issues | 25 |
| Budget/Appropriations | 11 |
| Medicare/Medicaid | 8 |